Vaunted as the largest in the world, India’s vaccine program is being hobbled by supply shortages and an abrupt shift in procurement policy that appears to be without parallel. The woes of the inoculation drive are especially striking given India’s unique advantages, including a large vaccine industry and a record of mass immunization campaigns.
Just months ago, public health experts were counting on India to play a crucial role in supplying coronavirus vaccines to the developing world. The government was so confident of its ability to meet domestic demand for vaccines that it allowed more than 60 million doses to be exported or donated to other countries between January and March.
Faced with surging infections, India suspended exports at the end of March and has begun importing Russia’s Sputnik vaccine to try to alleviate the shortfall in local production. Last week, the government acknowledged that vaccine shortages in India will persist at least until July.
“To cover the entire nation, please remember it will take a little while,” V.K. Paul, a senior health official, told reporters on Thursday. “We should accept that as a reality with humility.”